|
Name: Cloxazolam
Type: Benzodiazepine
AKA: Akton, Lubalix, Olcadil, Sepazon
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Cloxazolam, a thienodiazepine, was developed in the 1970s for its anxiolytic and sedative effects. It is similar to benzodiazepines and was used to treat anxiety and sleep disorders. Cloxazolam's use has been subject to regulatory controls due to concerns about dependence and abuse potential. Its role in medical treatments reflects broader trends in the development of anxiolytics.
|
|
V. Legal Information
Cloxazolam, a benzodiazepine, is classified as a Schedule IV controlled substance in the US, allowing limited medical use. It is similarly regulated in many countries due to its potential for abuse and dependency. The UNODC emphasizes the need for balanced regulation to ensure safe medical use while preventing misuse. Trends indicate ongoing control measures to monitor and regulate benzodiazepines.
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Cloxazolam is a benzodiazepine used as an anxiolytic and sedative. It causes sedation, reduced heart rate, and impaired motor function. Short-term use is effective for anxiety management and sleep disorders, but long-term use can lead to dependence, cognitive impairment, and significant health issues. Overdose risks include severe sedation, respiratory depression, and potential death. Safe use involves precise dosing and medical supervision. Recent research emphasizes its efficacy and associated risks.  |
|
VII. Psychological Effects
N/A
 |
|
VIII. Culture
Cloxazolam is a benzodiazepine with anxiolytic and sedative properties, classifying it as a downer. Short-term use reduces anxiety and induces relaxation, while long-term use can lead to dependence and withdrawal symptoms. Overdose risks include severe respiratory depression and potentially fatal outcomes. Safe dosages are medically prescribed, typically under 10 mg per day. Recent research highlights its efficacy in anxiety management but warns of addiction risks. Physical effects include drowsiness, dizziness, and impaired coordination.
 |